Mehmet F Ozkaynak

Trials

Studies that name Mehmet F Ozkaynak as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:10 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT01041638 · Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

  National Cancer Institute (NCI) · completed · High Risk Neuroblastoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Children's Oncology Group Chair's Grant
  U10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013
  Named on NCT01041638